---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-004821"
form_type: "8-K"
ticker: "RNLXY"
cik: "0001811115"
company_name: "Renalytix plc"
filed_at: "2024-01-17T23:59:59+00:00"
generated_at: "2026-06-06T22:39:02.404024+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.68
calibrated_materiality_score: 0.68
confidence: "high"
source: SEC EDGAR
---

# Renalytix announces LCD open meeting for kidneyIntelX.dkd; potential coverage for 5M more Medicare patients

## Summary
- NGS LCD Open Meeting scheduled for February 29, 2024 to discuss coverage of KidneyIntelX and kidneyintelX.dkd.
- Proposed LCDs published February 8, 2024; 45-day public comment period ends March 23, 2024.
- If covered, an estimated additional 5 million Medicare patients with Type 2 diabetes and early-stage CKD could gain access.
- New private payer contract with Velocity National Provider Network, covering 2.7 million member lives, effective January 2024.
- Final LCD expected during calendar year 2024 after public comment review.

## SEC filing metadata
- accession: 0000950170-24-004821
- form_type: 8-K
- ticker: RNLXY
- cik: 0001811115
- company_name: Renalytix plc
- filed_at: 2024-01-17T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.68
- calibrated_materiality_score: 0.68
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1811115/000095017024004821/0000950170-24-004821-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1811115/000095017024004821/rnlx-20240117.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-004821
- JSON: https://secwatch.observer/filing/0000950170-24-004821.json
- Plain text: https://secwatch.observer/filing/0000950170-24-004821.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.